Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A von Eckardstein

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Journal of Internal Medicine|May 20, 2020
Trimethyllysine and trimethylamine-N-oxide - pathogenic factors or surrogate markers of increased cardiovascular disease risk?A von Eckardstein
Praxis|December 7, 2007
[CME--laboratory 4. "Tumor marker"]A von Eckardstein
Praxis|May 12, 2007
[CME-Lab 2/Solution. Hypercholesteremia and therapy control]A von Eckardstein
Current Opinion in Lipidology|October 1, 1996
Cholesterol efflux from macrophages and other cellsA von Eckardstein
Praxis|May 18, 2007
[Hypercholesterolemia and control with therapy]A von Eckardstein
Handbook of Experimental Pharmacology|April 7, 2006
Risk factors for atherosclerotic vascular diseaseA von Eckardstein
The New England Journal of Medicine|December 31, 1997
Plasma homocysteine levels and mortality in patients with coronary artery diseaseA von Eckardstein, G Assmann
Current Atherosclerosis Reports|June 8, 2001
Clinical implications of elevated lipoprotein(a)A von Eckardstein, G Assmann
Current Opinion in Lipidology|November 22, 2000
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?A von Eckardstein, G Assmann
Handbook of Experimental Pharmacology|April 7, 2006
Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transportM Hersberger, A von Eckardstein
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Journal of Internal Medicine|May 20, 2020
Trimethyllysine and trimethylamine-N-oxide - pathogenic factors or surrogate markers of increased cardiovascular disease risk?A von Eckardstein
Praxis|December 7, 2007
[CME--laboratory 4. "Tumor marker"]A von Eckardstein
Praxis|May 12, 2007
[CME-Lab 2/Solution. Hypercholesteremia and therapy control]A von Eckardstein
Current Opinion in Lipidology|October 1, 1996
Cholesterol efflux from macrophages and other cellsA von Eckardstein
Praxis|May 18, 2007
[Hypercholesterolemia and control with therapy]A von Eckardstein
Handbook of Experimental Pharmacology|April 7, 2006
Risk factors for atherosclerotic vascular diseaseA von Eckardstein
The New England Journal of Medicine|December 31, 1997
Plasma homocysteine levels and mortality in patients with coronary artery diseaseA von Eckardstein, G Assmann
Current Atherosclerosis Reports|June 8, 2001
Clinical implications of elevated lipoprotein(a)A von Eckardstein, G Assmann
Current Opinion in Lipidology|November 22, 2000
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?A von Eckardstein, G Assmann
Handbook of Experimental Pharmacology|April 7, 2006
Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transportM Hersberger, A von Eckardstein
Pageof 14